Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M72.1Revenue (TTM) $M28.1Net Margin (%)-107.8Altman Z-Score-9.1
Enterprise Value $M159EPS (TTM) $-0.7Operating Margin %-119.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.3Pre-tax Margin (%)-107.4Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.7Cash flow > EarningsN
Price/Sales2.55-y EBITDA Growth Rate %0.5Current Ratio0.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-42.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-124.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M45.8ROIC % (ttm)-127.2Gross Margin Increase y-yY

Gurus Latest Trades with ALIM

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ALIM is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ALIM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
EISWIRTH RICHARD S JRPresident and CFO 2016-09-15Sell51,471$1.514.64view
BAVP, L.P.10% Owner 2016-04-21Sell478,673$2.59-39view
EISWIRTH RICHARD S JRCOO and CFO 2015-12-16Sell46,669$2.31-31.6view
Flynn James E 2015-12-08Buy272,249$3.01-47.51view
Flynn James E 2015-12-03Buy243,252$3-47.33view
Flynn James E 2015-11-06Buy73,250$2.98-46.98view
Flynn James E 2015-10-30Buy16,542$3-47.33view
Flynn James E 2015-10-28Buy59,342$3-47.33view
Flynn James E 2015-10-26Buy60,364$3-47.33view
Flynn James E 2015-10-21Buy390,040$2.97-46.8view

Quarterly/Annual Reports about ALIM:

    News about ALIM:

    Articles On GuruFocus.com
    Alimera Sciences Inc. (ALIM) President and CEO C. Daniel Myers sells 45,523 Shares Mar 16 2011 
    The Most Speculative Stocks on the Market: Harbinger, Kaching Kaching, Alimera Sciences, Star Scient Jul 29 2010 

    More From Other Websites
    ETF’s with exposure to Alimera Sciences, Inc. : September 20, 2016 Sep 20 2016
    Alimera Sciences Announces 23 Clinical Presentations and a Sponsored Symposium at 16th EURETINA... Sep 06 2016
    Alimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake Aug 23 2016
    Alimera Sciences Announces Exercise of Underwriters' Over-Allotment Option and Closing of $26.5... Aug 16 2016
    Alimera Sciences Announces Exercise of Underwriters’ Over-Allotment Option and Closing of $26.5... Aug 16 2016
    ALIMERA SCIENCES INC Financials Aug 13 2016
    ETF’s with exposure to Alimera Sciences, Inc. : August 12, 2016 Aug 12 2016
    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 Aug 11 2016
    Alimera Sciences Prices Public Offering of Common Stock Aug 11 2016
    ALIMERA SCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events Aug 11 2016
    Alimera Sciences Prices Public Offering of Common Stock Aug 11 2016
    Alimera Sciences Proposes Public Offering of Common Stock Aug 10 2016
    ALIMERA SCIENCES INC Files SEC form 8-K, Other Events Aug 10 2016
    Alimera Sciences Proposes Public Offering of Common Stock Aug 10 2016
    Alimera Sciences announces clinical presentations and sponsored Symposia at ASRS 2016 Annual meeting Aug 09 2016
    Alimera Sciences announces clinical presentations and sponsored Symposia at ASRS 2016 Annual meeting Aug 09 2016
    Edited Transcript of ALIM earnings conference call or presentation 4-Aug-16 2:00pm GMT Aug 05 2016
    ALIMERA SCIENCES INC Files SEC form 10-Q, Quarterly Report Aug 05 2016
    Alimera Sciences reports 2Q loss Aug 04 2016
    Alimera Sciences reports 2Q loss Aug 04 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)